Strides Arcolab is currently trading at Rs. 910.35, up by 27.50 points or 3.11% from its previous closing of Rs. 882.85 on the BSE.
The scrip opened at Rs. 896.95 and has touched a high and low of Rs. 927.85 and Rs. 896.95 respectively. So far 45739 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1224.90 on 05-Dec-2012 and a 52 week low of Rs. 675.25 on 27-Jul-2012.
Last one week high and low of the scrip stood at Rs. 889.90 and Rs. 868.00 respectively. The current market cap of the company is Rs. 5349.78 crore.
The promoters holding in the company stood at 27.39% while Institutions and Non-Institutions held 55.84% and 16.77% respectively.
Bangalore-based pharma major Strides Arcolab has received its board’s approval to increase the limit of investments by Foreign Institutional Investors (FIls) in the equity share of the company from 49 per cent to 74 per cent. The company’s board gave the approval for the same on July 4. 2013.
The ceiling for investment by FIIs in the equity share of the company was capped at 49 per cent of its paid-up equity capital.
Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.
